Option Investor
Newsletter

ONE NEW ADDITIONAL PLAY TO ADD TO JANUARY RECOMMENED LIST

HAVING TROUBLE PRINTING?
Printer friendly version


NEW ADDITION TO JANUARY RECOMMENDATION LIST:

Let's see if we can start off the New Year by adding one (1) new position to
our recommended list for JANUARY EXPIRATIONS

We are recommending put writes in the following issue:

PPCO - Penwest Pharmaceuticals Co.
develops pharmaceutical products based on proprietary oral drug delivery technologies primarily in North America and Europe.
The company is developing two drug development pipelines, which include oxymorphone ER, an extended release formulation of oxymorphone, a narcotic analgesic being developed for twice-a-day dosing in patients with moderate to severe pain requiring opioid therapy for an extended period of time; and PW2101, a beta blocker intended for the treatment of hypertension and angina. Its drug delivery technologies include TIMERx, an extended release delivery system that is adaptable to soluble and insoluble drugs, as well as flexible for a various controlled release profiles; Geminex, a dual drug delivery system to provide independent release of different active ingredients contained in a drug; SyncroDose, a drug delivery system to release the active ingredient of a drug at the desired site and time in the digestive tract; and Gastroretentive system, a drug delivery system to provide controlled release delivery of drugs that are absorbed in the stomach and upper portions of the GI tract, without a loss of bioavailability. Penwest Pharmaceuticals is also developing various additional product candidates in areas, such as edema, epilepsy, schizophrenia, and depression.

We are recommending the following specific put write

PPCO PRICE $19.52

SELL PPCO JAN SYM: OGQ-MW
Target Price $20.00 17.5 Put
Potential Profit(10 x = $200.00
Initial Margin $4,104 10 (contracts)
Return on Investment 4.87%
Cost Basis in Stock = $17.30
Days to Expiration = 40
STOP EXIT STRATEGY
Close option position if Stock drops to => 17.50


This will bring our total January Recommendation list to nine (9) positions.


We also will be adding SUPPLEMENTAL TRADES in a separate email blog a little
later today.


Option Writers Newsletter Archives